# Opus Genetics (IRD) — Earnings

IRD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ird/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.12 |
| EPS estimate | −$0.21 |
| EPS surprise | +41.46% |
| Revenue surprise | −28.84% |
| Revenue | $2.9M |
| Revenue estimate | $4.0M |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1228627/000114036125030836/ef20050389_10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$0.21 | −$0.12 | 41.46% | $4.0M | $2.9M |
| Q1 2025 | May 15, 2025 | −$0.25 | −$0.24 | 4.00% | $3.1M | $4.4M |
| Q4 2024 | Mar 31, 2025 | −$0.25 | −$1.27 | -418.37% | $3.4M | $4.3M |
| Q3 2024 | Nov 12, 2024 | −$0.24 | −$0.29 | -22.11% | $2.3M | $3.9M |
| Q2 2024 | Aug 13, 2024 | −$0.26 | −$0.30 | -17.65% | $2.5M | $1.1M |
| Q1 2024 | May 10, 2024 | −$0.11 | −$0.29 | -163.64% | $5.3M | $1.7M |
| Q4 2023 | Mar 8, 2024 | −$0.05 | −$0.21 | -300.00% | $5.4M | $1.7M |
| Q3 2023 | Nov 13, 2023 | −$0.22 | $0.25 | 212.61% | $3.0M | $11.9M |
| Q2 2023 | Aug 11, 2023 | −$0.23 | −$0.24 | -6.19% | $2.4M | $3.7M |
| Q1 2023 | May 15, 2023 | −$0.15 | −$0.28 | -81.82% | $3.0M | $1.7M |
| Q4 2022 | Mar 30, 2023 | $1.32 | $1.58 | 20.15% | $29.4M | $39.9M |
| Q3 2022 | Nov 4, 2022 | −$0.28 | −$0.22 | 21.99% | — | — |
| Q2 2022 | Aug 12, 2022 | −$0.33 | −$0.25 | 24.70% | — | — |
| Q1 2022 | May 13, 2022 | −$0.35 | −$0.35 | 0.00% | — | — |
| Q4 2021 | Mar 24, 2022 | −$0.29 | −$0.35 | -21.53% | — | — |
| Q3 2021 | Nov 12, 2021 | −$0.36 | −$0.25 | 30.17% | — | $489,000.00 |
| Q2 2021 | Aug 12, 2021 | −$0.38 | −$0.52 | -35.95% | — | $100,000.00 |
| Q1 2021 | May 7, 2021 | −$0.71 | −$3.57 | -401.05% | — | — |

## Frequently Asked Questions

### When did Opus Genetics (IRD) last report earnings?

Opus Genetics last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did IRD beat earnings estimates?

Yes. Opus Genetics reported EPS of −$0.12 for Q2 2025 against a −$0.21 estimate — a 41.46% beat.

### How much revenue did IRD report last quarter?

Opus Genetics reported $2.9M in revenue for Q2 2025, against a consensus estimate of $4.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).